The AQP2 gene plays a crucial role in the body's water balance mechanism, specifically in the kidney's ability to concentrate urine. Mutations in the AQP2 gene can lead to Nephrogenic Diabetes Insipidus (NDI), a condition characterized by the kidney's inability to respond to the antidiuretic hormone, leading to excessive production of dilute urine, dehydration, and a constant need for water. NDI can be inherited in an autosomal manner, meaning the genetic mutation can be passed down from parents to offspring.
To diagnose this condition, a genetic test focusing on the AQP2 gene can be conducted. This test is crucial for identifying the specific mutation within the AQP2 gene that is causing NDI. Early diagnosis and identification of the genetic mutation are essential for managing symptoms and preventing complications associated with NDI.
In the UAE, this specific genetic test for the AQP2 gene can be performed at DNA Labs UAE. The test cost is set at 4400 AED. DNA Labs UAE offers comprehensive genetic testing services, ensuring accuracy and confidentiality in the diagnosis of Nephrogenic Diabetes Insipidus and other genetic conditions. This test is a vital tool for families with a history of NDI, providing them with the necessary information for managing the condition and making informed health decisions.
The ABCC2 gene, associated with Dubin-Johnson Syndrome, is a critical focus for genetic testing at DNA Labs UAE. Dubin-Johnson Syndrome is a rare genetic disorder characterized by an increase of conjugated bilirubin without elevation of liver enzymes (ALT, AST). It's a condition that affects the liver's ability to process certain substances, leading to jaundice. This syndrome is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected.
The genetic test for Dubin-Johnson Syndrome at DNA Labs UAE specifically targets mutations in the ABCC2 gene, which encodes for a protein essential for the proper functioning of the liver. Mutations in this gene disrupt the liver's ability to transport certain compounds, including bilirubin, leading to the symptoms associated with the syndrome.
The cost of the ABCC2 gene test for Dubin-Johnson Syndrome at DNA Labs UAE is 4400 AED. This comprehensive test is designed to provide accurate diagnosis, which is crucial for the management and treatment of the condition. Early diagnosis can help in managing symptoms effectively and in making informed decisions about the care and treatment of individuals with the syndrome.
The "ICK Gene Endocrine-Cerebroosteodysplasia Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the ICK gene, which have been linked to endocrine-cerebroosteodysplasia (ECO), a rare genetic disorder. This condition is characterized by a spectrum of symptoms including endocrine abnormalities, developmental delays, and skeletal malformations. The test is crucial for early diagnosis and management of the disorder, offering insights into potential treatments and interventions that can improve the quality of life for affected individuals. Priced at 3200 AED, the test involves collecting a DNA sample from the patient, which is then analyzed using advanced genetic sequencing techniques to detect any abnormalities in the ICK gene. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step forward in the personalized medicine and genetic understanding of rare diseases.
The MYH9 Gene Epstein Syndrome Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, aimed at detecting mutations in the MYH9 gene, which are associated with Epstein Syndrome. Epstein Syndrome is a rare genetic disorder characterized by a combination of symptoms including nephritis (kidney inflammation), hearing loss, and abnormalities in blood platelets. The MYH9 gene plays a crucial role in the development and function of platelets, kidney cells, and inner ear structures. Mutations in this gene can disrupt these processes, leading to the symptoms observed in Epstein Syndrome.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any genetic mutations in the MYH9 gene. This genetic test is essential for the accurate diagnosis of Epstein Syndrome, enabling targeted management and treatment strategies for affected individuals. It is also valuable for at-risk family members who may want to understand their risk of passing the condition onto their offspring.
At DNA Labs UAE, the MYH9 Gene Epstein Syndrome Genetic Test is priced at 4400 AED. This cost covers the comprehensive analysis required to detect the specific genetic mutations associated with the syndrome. Opting for this test at DNA Labs UAE ensures that patients receive accurate and reliable results, thanks to the lab's state-of-the-art technology and experienced genetic specialists. Early diagnosis through this test can significantly improve the quality of life for individuals with Epstein Syndrome by facilitating timely interventions and support.
The ESR1 Gene Estrogen Resistance Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the ESR1 gene, which can lead to estrogen resistance. This condition can have significant implications for bone density, reproductive health, and the risk of certain cancers. By identifying mutations in the ESR1 gene, healthcare providers can better understand an individual's risk factors and tailor treatment and management plans accordingly. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accurate and reliable results. This test is particularly relevant for individuals with a family history of estrogen resistance or related health conditions, offering them a proactive approach to managing their health.
The BBS12 Gene Bardet-Biedl Syndrome Type 12 Genetic Test is a specialized diagnostic examination designed to identify mutations in the BBS12 gene, which are associated with Bardet-Biedl Syndrome (BBS) Type 12. BBS is a complex genetic condition characterized by symptoms such as vision loss, kidney dysfunction, obesity, learning disabilities, and extra fingers or toes. The BBS12 gene plays a critical role in cell functioning and structure, and mutations in this gene can lead to the development of the syndrome.
Conducted at DNA Labs UAE, this test is a crucial tool for individuals with a family history of BBS or those exhibiting symptoms of the syndrome, offering them a definitive diagnosis. By analyzing a sample of the patient's DNA, the test can detect specific genetic alterations in the BBS12 gene, confirming the presence of Bardet-Biedl Syndrome Type 12.
The cost of the BBS12 Gene Bardet-Biedl Syndrome Type 12 Genetic Test is 4400 AED. While the price may seem significant, the test provides invaluable information for the management and treatment of the syndrome, potentially improving the quality of life for those affected. Early diagnosis through genetic testing allows for timely intervention, including specialized care and support, to address the various health issues associated with BBS.
The MKS1 Gene Bardet-Biedl Syndrome Type 13 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the MKS1 gene, which are linked to Bardet-Biedl Syndrome (BBS) Type 13. BBS is a rare genetic disorder that affects multiple body systems, leading to symptoms such as vision loss, obesity, kidney dysfunction, and polydactyly, among others. The test plays a crucial role in the early detection and management of this condition, enabling healthcare providers to develop personalized treatment plans and offer genetic counseling to affected families. Priced at 4400 AED, this test offers invaluable insights into the genetic basis of Bardet-Biedl Syndrome, facilitating improved patient outcomes through targeted interventions.
The CEP290 Gene Bardet-Biedl Syndrome Type 14 Genetic Test is a sophisticated diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CEP290 gene, which are associated with Bardet-Biedl Syndrome Type 14 (BBS14). Bardet-Biedl Syndrome is a complex genetic disorder that affects multiple body systems, leading to symptoms such as vision loss, kidney dysfunction, obesity, polydactyly, and learning difficulties, among others. The CEP290 gene plays a crucial role in the structure and function of cells, particularly in cilia, which are important for cell signaling and organ development.
This test is vital for individuals with a family history of Bardet-Biedl Syndrome or those exhibiting symptoms, as it can provide a definitive diagnosis, enabling early intervention and management of the condition. The genetic test involves analyzing the patient's DNA to detect mutations in the CEP290 gene that are indicative of BBS14. Early diagnosis through genetic testing can significantly impact the patient's quality of life by allowing for personalized management strategies and preventive measures for potential complications.
DNA Labs UAE offers this test for a cost of 4400 AED. The facility is equipped with state-of-the-art technology and staffed by professionals with expertise in genetic testing, ensuring accurate and reliable results. Patients and healthcare providers considering this test can expect a thorough and confidential handling of the diagnostic process, from sample collection to the interpretation of results.
The WDPCP Gene Bardet-Biedl Syndrome Type 15 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the WDPCP gene, which are linked to Bardet-Biedl Syndrome Type 15 (BBS15). Bardet-Biedl Syndrome is a complex genetic condition characterized by symptoms such as retinal degeneration, obesity, kidney dysfunction, and additional features affecting various parts of the body. The test is crucial for individuals with a clinical diagnosis or family history of BBS, as it provides essential information for accurate diagnosis, management, and genetic counseling. The testing process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations in the WDPCP gene. The cost of the test at DNA Labs UAE is 4400 AED, reflecting the comprehensive analysis and detailed reporting provided. This genetic test is a valuable tool for affected families, offering insights into the condition and aiding in the development of personalized treatment plans.
The BBS2 Gene Bardet-Biedl Syndrome Type 2 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the BBS2 gene, which are known to cause Bardet-Biedl Syndrome (BBS) Type 2. BBS is a complex genetic condition that affects multiple body systems, presenting with symptoms such as vision loss, kidney dysfunction, obesity, learning disabilities, and extra fingers or toes. Early and accurate diagnosis through genetic testing can be crucial in managing and treating the condition effectively.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA sample (usually obtained from blood) to look for specific genetic alterations in the BBS2 gene that are indicative of the syndrome. The cost of the test is set at 4400 AED, reflecting the intricate processes and expertise required to accurately identify the genetic markers associated with the condition.
Choosing to undergo the BBS2 Gene Bardet-Biedl Syndrome Type 2 Genetic Test at DNA Labs UAE ensures access to state-of-the-art genetic testing technologies, along with the support of experienced genetic counselors and specialists who can provide comprehensive guidance and interpretation of the test results. This facilitates a better understanding of the condition, allowing for personalized management plans and interventions that can significantly improve the quality of life for individuals affected by Bardet-Biedl Syndrome Type 2.
